Ionis Pharma's genetic disease drug succeeds in late-stage study

In this article:

Jan 22 (Reuters) - Ionis Pharmaceuticals said on Monday its therapy for the treatment of a rare genetic disease met the main goal in a late-stage trial. (Reporting by Sriparna Roy in Bengaluru; Editing by Devika Syamnath)

Advertisement